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GABA levels, high affinity GABA uptake and glutamic acid decarboxylase levels are reduced in 
rat ventroanterolateral thalamic nucleus after destruction of the entopeduncular nucleus with kainic 
acid. This is strong evidence that GABA is an entopedunculothalamic neurotransmitter. The striato- 
entopeduncular pathway is also GABAergic. Thus the function of the corpus striatum may be to 
disinhibit the thalamus. 
The abnormal involuntary movements seen in Huntington's disease, Parkinson's 
disease, tardive dyskinesia and athetoid cerebral palsy are presumed to result in part 
from dysfunction of the neostriatum (caudate nucleus and putamen) 1. These move- 
ments include chorea, athetosis, dystonia and bradykinesia. How neostriatal dys- 
function leads to these symptoms is unknown. Except in Parkinson's disease, pharma- 
cologic treatment of these abnormal movements has been disappointing. Occasionally, 
surgical therapy has proved successful especially when the surgical lesion is in the 
ventroanterior and ventrolateral nuclei (VL) of the thalamus 3. The success of these 
operations suggests that these abnormal movements are dependent on the integrity of 
VL. The part of VL which projects to motor cortex receives a major output from the 
basal ganglia via the medial segment of the globus pallidus (MPS) (Fig. 1, left side)2,10. 
The MPS in turn receives output from neostriatal neurons which also send collaterals 
to the substantia nigra 14. Thus these pathways from neostriatum to ventroanterior 
and ventrolateral thalamus via the medial pallidal segment may play an important role 
in the generation of abnormal movements. The neurotransmitter of medial pallidal 
cells is unknown. We have recently attempted to demonstrate the neurotransmitter of 
the pallidothalamic pathway in rats by studying neurotransmitter functions in ventro- 
lateral nucleus of the thalamus after injection of kainic acid into the murine counter- 
part of the medial pallidal segment, the entopeduncular nucleus (EP). 
Kainic acid (Sigma), 0.1 M solution, pH 7.0, was iontophoresed stereotaxically 
into the right EP of Sprague-Dawley rats (150-200 g)lL Stereotaxic coordinates were 
A.P. --5.2 mm, M.L. --2.7 ram, D.V. --1.8 mm 1~. Angled injections from 30 ° 
forward, passing through prefrontal cortex, striatum and globus pallidus, were used. 
Negative current (1 mA) was passed through 40/zm tip glass micropipettes with 500 
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msec on/500 msec off pulses for 10 min s. Two weeks after injection, the animals were 
sacrificed by decap;tation. The brains were rapidly removed and put into cold 0.32 M 
buffered sucrose. Coronal sections (1 mm) were made through the diencephalon and 
punches one millimeter in diameter were taken bilaterally from the ventroanterolateral 
nucleus (the rat's equivalent of VL) (see Fig. 1). Punches were either frozen 
immediately on dry ice and stored at --70 °C for later determination of tissue amino 
acid levels or placed in the appropriate buffer and assayed for L-glutamate-1- 
carboxylase (EC 4.1.15, GAD) 6 or high affinity synaptosomal uptake 2°. Levels of 
amino acids were determined in ethanol extracts of the frozen punches by high 
performance liquid chromatography. Amino acid levels were determined fluorometri- 
cally as their o-phthaldialdehyde derivatives by a modification of previous techniques 
using a Spheri 5A 5-C18 reverse phase column (Brownlee) and a gradient from 22 to 
40 ~ B where B is methanol and A is 0.1 M potassium acetate buffer pH 5.5 plus 5 ~o 
tetrahydrofuran 9,13. The remainder of the slices and the rest of the brains were placed 
in 10 ~ buffered formalin for one week. Sections of 40/~m were then cut and stained 
with cresyl violet. Two rats were perfused and the brains processed according to the 
method of Fink and Heimer to demonstrate degenerating terminalsL Four rats were 
decorticated and assayed as above to control for the possibility that the pipettes or the 
kainic acid might also destroy fibers traveling through the lesion from cortex to 
ventroanterolateral nucleus. 
Cresyl violet-stained sections revealed destruction of 50-90 ~ of the entope- 
duncular neurons. Some lesions also involved the putamen, the amygdala or the lateral 
globus pallidus. Animals in which the lesion encroached on the thalamus or in which 
the punches were not entirely in VL were excluded. 
The t~rains processed by the Fink-Heimer technique revealed degeneration in 
the thalamic nuclei to which the entopeduncular nucleus is thought to project: ventro- 
anterolateralis, lateral habenula and parafasicularisL There were also degenerating 
terminals in the subthalamic nucleus, lateral hypothalamus and bed nucleus of the 
stria terminalis presumably because lateral globus pallidus and amygdala were 
lesioned1,12. 
Amino acid levels in ventroanterolateralis of the lesioned and unlesioned sides 
show no decrease in glycine, taurine, glutamate, aspartate, glutamine or threonine 
(Table I). There is a 54 ~ decrease (P < 0.01) in the inhibitory amino acid, gamma- 
aminobutyric acid (GABA). The decrease is very selective and so we also measured 
two other presynaptic GABAergic markers, glutamic acid decarboxylase (GAD) and 
high affinity GABA uptake in a series of similarly lesioned animals. There is a 46 
decrease in GAD (P < 0.01) and a 47~ decrease in high affinity GABA uptake (P < 
0.01) (Table I). Animals with kainic acid lesions along the needle tract but not 
involving entopeduncular nucleus had no change in GAD in VL (lesioned side, 35.2 ± 
5.0 nmol CO2/h/mg prot., control side, 39.6 ~: 9.4). 
Some might argue that the decrease in GABAergic markers in thalamus results 
from the amygdalar, striatal or lateral pallidal lesions and not from the lesion of the 
entopeduncular cells. However, no projections from these nuclei to VL are known. If 




GABA and GAD levels and high affinity GABA uptake in ventroanterolateral thalamic nucleus o f  rats 
2 weeks after unilateral injection ofkainic acid into the entopeduncular nucleus 
Ventroanterolateral thalamus 
Lesioned side Control side 
Amino acid ( n = 4) ( ttmol /gwet weight) 
Aspartate 2.88 =k 0.12 2.62 4- 0.20 
Glutamate 15.1 ± 2.0 13.1 d: 0.5 
Glutamine 4.53 :k 0.31 4.26 ± 0.29 
Glycine 0.72 -4- 0.13 0.78 ~ 0.14 
Threonine 0.95 ± 0.06 1.00 ± 0.06 
Taurine 2.76 ± 0.16 2.89 -+- 0.06 
GABA 0.94 ± 0.14" 2.05 ± 0.17 
GAD (n = 4) (nmolCO2/h/mgprot.) 23.1 ± 3.2* 42.5 ± 1.5 
GABA uptake (n = 4) (nmol/S min/mgprot.) 0.17 ± 0.04* 0.32 4- 0.05 
* P < 0.01. Values represent the mean q- the standard error of the mean of determinations on groups 
of 4 animals. 
It  is doubtful that  the GABA changes in ventroanterolateralis are due to damage 
of corticothalamic pathways (Fig. 1, right side) by the pipette or by kainate since 
unilaterally decorticate animals show no change in GABA in ventroanterolateralis on 
the lesioned side (lesioned side, 2.72 ± 0.29 #mol/g;  control side, 2.65 dz 0.21). 
The medial pallidal segment receives a major input from GABAergic cells in the 
neostriatum 14. I f  the GABAergic pallidothalamic cells receive GABAergic input from 
the striatopallidal cells there would be two sequential GABAergic inhibitory neurons 
connecting the striatum and the thalamus. The medial pallidal cells have been shown 
neurophysiologically to be tonically active 7 and inhibitory onto thalamocortical cells 
in ventrolateralis 19. It  has not been established that striatopallidal cells make direct 
synaptic contact with pallidothalamic cells. If, however, such a connection exists, an 
active GABAergic output cell of  the striatum would inhibit medial pallidal output cells 
thus 'disinhibiting' i.e. activating, certain thalamic cells 1~. A sequential order of  
striatomedialpallidal and pallidothalamic GABAergic neurons would explain the 
previously observed clinical phenomenon that low doses of  GABA mimetic drugs 
reduce the chorea of Huntington's  disease while higher doses are without effect is. The 
GABAergic striatopallidal cells degenerate in Huntington's  disease 15 and super- 
sensitive GABA receptors develop in the globus pallidus 4. Low doses of  GABAergic 
agents might alleviate chorea by interacting preferentially with the supersensitive 
receptors in the pallidum while higher doses counteract this effect by actions in the 
thalamus. 
In summary, GABAergic markers are reduced substantially in ventrolateral 
thalamus after selective destruction of the entopeduncular nucleus neurons in rat. The 
entopeduncular nucleus is the murine equivalent of  the medial globus pallidus. We 
suggest that  the inhibitory entopedunculothalamic neurons utilize GABA as a neuro- 
transmitter. 
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Fig. 1. Site of kainate lesion and punches, a: line drawing of the rostral surface of the rat brain slice 
from which 1 mm punches are taken. This is superimposed on a line drawing of the midbrain. Large 
circle shows the extent of a typical lesion. Small circle shows the site of the punches. Arrows show the 
direction of basal ganglia feedback loops: corticothalamic (right), corticostriatopallidothalamic (left) 
and striatonigral (bottom). Abbreviations: Cx, cortex; EP, entopeduncular nucleus; P, putamen 
(striatum); SN, substantia nigra; VL, ventroanterolateral nucleus of thalamus, b: Fink-Heimer stain 
of VL from unlesioned side. Only cell nuclei take up the black stain, c: Fink-Heimer stain of VL from 
lesioned side. Degenerating fibers and axon terminals as well as nuclei take up the stain. 
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